Hard-to-Treat Group Trips Up HCV Drug
(MedPage Today) — A promising hepatitis C medication has run into a roadblock in a small group of hard-to-treat patients, according to the drug’s maker.
Article printed from Gastroenterology Education and CPD for trainees and specialists: https://www.gastrotraining.com